Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Buy
122,900
+7,019
+6% +$822K 0.51% 49
2026
Q1
$13.9M Buy
115,881
+5,261
+5% +$607K 0.94% 26
2025
Q4
$11.6M Buy
110,620
+31,887
+41% +$2.99M 0.9% 21
2025
Q3
$6.61M Buy
78,733
+39,849
+102% +$3.28M 0.55% 50
2025
Q2
$3.08M Sell
38,884
-306
-0.8% -$24.3K 0.82% 44
2025
Q1
$3.52M Buy
39,190
+27,848
+246% +$2.6M 1.05% 24
2024
Q4
$1.13M Buy
+11,342
New +$1.17M 0.47% 58

Other funds holding MRK

Tema ETFs's MRK Position: Q2 2026 in Review

Tema ETFs increased its Merck (MRK) stake by 6.1% in Q2 2026, buying an estimated $822K and bringing the position to 122,900 shares worth $15.8M. The position accounts for 0.51% of the portfolio, ranked #49.

Tema ETFs first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tema ETFs held 122,900 shares of Merck worth $15.8M as of Q2 2026.
  • Tema ETFs bought 7,019 Merck shares in Q2 2026, an estimated $822K.
  • Merck made up 0.51% of Tema ETFs's portfolio in Q2 2026, its #49 holding.
  • Tema ETFs first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.